TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$18.91
−0.73%Forward multiples
Based on analyst estimates
- P/E forward
- 39.76x
- P/E 2026E
- 46.82x
- P/E 2027E
- 29.26x
- P/E 2028E
- 23.93x
- P/S forward
- 2.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- 51.23x
- PEG TTM
- 1.78x
- Price / book
- 1.25x
- Price / sales
- 2.02x
- Price / cash flow
- 9.88x
Enterprise value
- Enterprise value
- $88.7B
- EV / sales
- 2.97x
- EV / EBITDA
- 10.91x
- EV / EBIT
- 27.01x
- Market cap
- $60.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026